Skip to content
POM-V Prescription Required

Scabigard Cutaneous Suspension

Active ingredient: Orf virus

Form

Injection

Species

Sheep

Manufacturer

Zoetis UK Limited

VMD MA No.

42058/5173

What it's used for

Onset of immunity: 4 - 8 weeks. Duration of immunity: at least 1 year.

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Orf virus

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Scabigard Cutaneous Suspension — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Onset of immunity: 4 - 8 weeks.
Duration of immunity: at least 1 year.
Administration: by skin scarification.
This vaccine must be administered to sheep and lambs using an applicator, such as
the Scabigard Applicator, that dispenses a 0.02 ml dose of vaccine and prevents
back flush.
At the site of vaccination, erythema local to the line(s) of scarification are to be
expected as the initial, observable effect, days 1-14 post-vaccination. Vesicles and
pustules may then be observed, from approximately day 3-14 post-vaccination, and
restricted to the site of scarification. Rupture of these vesicles and pustules, and scab
formation, can be expected from about day 7 post-vaccination. These effects are
expected in up to 100% of animals treated and are commonly referred to as vaccine
“take”; they indicate successful vaccination. In susceptible animals (those at risk of
orf virus infection) the aim is to obtain a “take” in each animal vaccinated.
Susceptible sheep or lambs must “take” in order to become immunised against orf
disease. Failure to “take” may be due to poor vaccination technique, improper
handling of the vaccine resulting in loss of potency, or because the sheep are already
immune. Revaccination once should be considered where a “take” has not occurred.
It is strongly recommended that the effectiveness of vaccination be assessed by
examination of a selected group of sheep and/or lambs, one week to 10 days after
vaccination. A more or less continuous line of pustules should be visible along the
track of the scratch made on the skin. The pustules progress to form scabs which
gradually dry and fall off by 7 weeks after vaccination.
Treatment of Ewes (site and method of administration):
Do not vaccinate ewes less than 7 weeks before lambing. The site of administration
is behind the elbow or in the axilla (i.e., between the top of the foreleg and the chest
wall), to prevent infection of the udder and subsequent transmission to lambs. Refer
to Figure 1 below.
Treatment of Lambs (site and method of administration):
Lambs may be vaccinated at any time from birth. Young (i.e. unweaned) lambs
should be vaccinated in the axilla. Refer to Figure 1.
Figure 1: Correct site for vaccine administration.
Vaccinate behind the elbow, in the hairless skin of the
axilla.
Restrain the lamb or sheep over a rail or similar with the bare skin exposed. To apply
the vaccine, place the Applicator prongs onto the skin and commence making a 4 to
5 cm scratch. The vaccine dose will be evenly deposited along the scratch. The
Applicator must be held at an angle to the skin (approximately 45 degrees). Press
firmly to ensure there is sufficient skin damage to enable an effective vaccination
“take”. The scratch should be just sufficient to break the top layer of the skin but not
deep enough to draw blood.
Recommendations when using the Scabigard Applicator:
•
•
operator.
•
can go no further.
•
bottle.
•
is in the locked position. Holding the vaccinator so that it points to the ground,
press down on the base of the vaccine bottle in a “pump like” action. Priming
should take approximately 10 pumps. When the vaccine flows onto the
scratcher prongs, the Applicator is primed and ready for use.
•
Applicator prongs until the product is applied.
•
pumped once to recharge the Applicator prongs with a precise dose of
vaccine.
•
end of each vaccination session, the Applicator should be (re)sterilised. Do not
use disinfectants to clean the Applicator as residues may harm the vaccine
when next used.
•
tissue to remove grease, dirt and wool collected from the sheep’s skin, taking
care not to contaminate the hands. It is advisable to have a plastic bag open
and pinned up to receive used materials. Sterilise used materials as soon as
possible after use.
Do not use this vaccine on farms or in flocks where orf disease is not a problem.
Do not vaccinate ewes less than 7 weeks before lambing.
Do not vaccinate pregnant ewes except at the recommended stage of pregnancy.
Do not vaccinate ewes or lambs during wet weather.
Sheep:
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
Injection site lump, injection site
swelling, injection site granuloma
Bacterial skin infection
1
Specific therapy may be required.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.
Vaccinate healthy animals only.

Special precautions for safe use in the target species:
The veterinary immunological product is a live virus vaccine, and thus care must be
taken to apply the vaccine only to the intended vaccination site and to not
contaminate other sites such as mouth, feet, superficial wounds or abraded skin of
the animal. Vaccinated lambs may transmit the disease to ewes’ udders.
Ewes that are vaccinated prior to lambing should not be moved to the proposed
place of lambing until sufficient time has passed for the scabs to drop off (minimum of
7 weeks).
Where indoor housing is practiced, routine cleansing and disinfection of the premises
is an important aid in the control of orf. In cases where vaccination of lambs cannot
be delayed until turnout, veterinary advice should be sought as to how to minimise
the risk of infection.
Ewes with unvaccinated lambs at foot are best to have their vaccination delayed until
the lambs are weaned, except in case of emergency. Vaccinate these ewes as for
pregnant ewes.
For a period of up to 7 weeks after vaccination, or until the scabs resulting from the
vaccine “take” have dropped totally, animals will be shedding virus infected scabs.
During this time, vaccinated animals should not be:
•
will subsequently be grazed,
•
species,
•
Vaccination of ewes before lambing will not provide protective immunity to the lambs
via the colostrum. Therefore, if orf disease is a problem in the lamb flock as well, the
lambs should also be vaccinated to ensure protection throughout the entire flock.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Orf disease is caused by a virus which is communicable to man. The vaccine is
capable of causing a skin infection in humans so should not be used by immuno-
suppressed individuals.
In the case of accidental self-administration (injection or scratch), ingestion or
spillage onto the skin or into the eye, seek medical advice immediately and show the
package leaflet or the label to the physician.
Personal protective equipment consisting of rubber gloves should be worn when
handling the veterinary immunological product or dismantling the applicator. Wash
hands and arms after vaccination.
Special precautions for the protection of the environment:
Care must be taken not to contaminate the ground area with vaccine or used
materials due to the persistence of orf virus in the environment.
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case-by-
case basis.
Care should be taken to avoid treatment of the animals near the period of vaccination
with substances or medicaments that might interfere with the “take” of this live
vaccine.
Store and transport refrigerated (2 °C – 8 °C).
Protect from light.
This product does not contain preservative to reduce or stop micro-organism growth.
Therefore, the in-use shelf life and storage conditions must be strictly adhered to.
Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance
Same active ingredient

Other Products Containing Orf virus

These products share the same active ingredient and may be suitable alternatives. Always consult your vet.

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.